comprehensive -WSS

comprehensive

author：comprehensive 2025-10-02 00:17:59 - browse：717

SAN DIEGO — Months after announcing plans to cut costs by $100 million, DNA sequencing giant Illumina has begun to lay off 10% of its research and development team, according to internal emails obtained and reviewed by STAT.

The layoffs, which began last Wednesday, impact research teams across the company’s California sites in San Diego and Foster City, as well as locations in Madison, Wisconsin; Singapore; and the United Kingdom. Alex Aravanis, the company’s chief technology officer, noted in an internal message that these cuts affect a tenth of research and development staff. The company’s also planning to shut down all lab-based research and development work in Foster City, according to a note from Steve Barnard, vice president of technology development.

Barnard’s note mentions that all affected employees have already been notified. And a separate message from interim CEO Charles Dadswell makes clear last week’s layoffs won’t be the last.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Be careful with at

hotspot

WSS

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

SCOTUS to consider access to abortion pill mifepristone

Illumina slashes 2023 revenue projections yet again

What PEPFAR has meant on the ground in Ukraine

Pfizer plans to depart BIO

Treatments for cramps don't cut it. Why aren't there better options?

focus

comprehensive

Wikipedia

Virginia high school admissions case could be legal follow

Be careful with at

Cancer drug shortages should be causing more outrage

Biogen’s boardroom scandal saddles CEO with first crisis

Heart attack and stroke risk calculators need revising

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

23andMe had bad news about my health. I wish a person had delivered it

Pregnancy discrimination could be enabled by AI

How to save PrEP access — and even expand it

Chemotherapy shortages won’t get better under Biden’s latest plan

focus

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

STAT letters to the editor on burnt

Idaho college killings prosecutors challenge defense's grand jury claims

Pharma patents targeted by Biden in move to slash drug prices

Bird flu researchers hone in on Finland’s mink farms

Patients' immediate access to test results puts radiologists in a bind

entertainment

explore

hotspot

Wikipedia